Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/038 stock hub

FRA/038 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/038is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.8B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/038FRA/038
Loading chart…
In the news

Latest news · FRA/038

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-50
P25 n/aP50 n/aP75 n/a
ROIC-131.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/038 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
172
Groups with data
11
Currency
USD
Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Jersey
Country code
DE
Employees
1,605
Employees Change
35%
Employees Change Percent
2.41
Enterprise value
EUR 1.6B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 1.8B
Price
EUR 14.76
Price currency
EUR
Rev Per Employee
364,435.68x
Sic
3845
Symbol
fra/038
Website
https://www.novocure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-8.53%
EV Earnings
-10.61x
EV/FCF
-38.21x
EV/Sales
2.78x
FCF yield
-2.37%
P/B ratio
6.14x
P/S ratio
3.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-26.71%
EBITDA Margin
-24.65%
Gross margin
75.45%
Gross Profit
EUR 441.3M
Gross Profit Growth
5.85%
Gross Profit Growth Q
16.01%
Gross Profit Growth3 Y
7.79%
Gross Profit Growth5 Y
3.95%
Net Income
EUR -150.1M
Pretax Margin
-25.98%
Profit Margin
-25.66%
Profit Per Employee
EUR -93,510
ROA
-11.06
Roa5y
-7.44
ROCE
-31.59
ROE
-49.96
Roe5y
-34.39
ROIC
-131.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
4.22%
Cagr1y
7.78%
Cagr3y
-37.56%
Cagr5y
-37.96%
Revenue Growth
8.48x
Revenue Growth Q
12.3x
Revenue Growth3 Y
8.88x
Revenue Growth5 Y
5.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.66
Assets
EUR 683.4M
Cash
EUR 374.7M
Current Assets
EUR 535.6M
Current Liabilities
EUR 184.5M
Debt
EUR 203.8M
Debt Equity
EUR 0.71
Debt FCF
EUR -4.89
Equity
EUR 286.8M
Interest Coverage
-9.18
Liabilities
EUR 396.5M
Long Term Assets
EUR 147.7M
Long Term Liabilities
EUR 212M
Net Cash
EUR 170.9M
Net Cash By Market Cap
EUR 9.71
Net Cash Growth
-15.21%
Net Debt Equity
EUR -0.6
Tangible Book Value
EUR 286.8M
Tangible Book Value Per Share
EUR 2.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.9
Inventory Turnover
3.99
Net Working Capital
EUR -15.5M
Quick ratio
2.66
Working Capital
EUR 359.1M
Working Capital Turnover
EUR 1.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
51.23%
1Y total return
7.78%
200-day SMA
10.5
3Y total return
-75.67%
50-day SMA
10.66
50-day SMA vs 200-day SMA
50over200
5Y total return
-90.81%
All Time High
203.2
All Time High Change
-92.74%
All Time High Date
2021-04-13
All Time Low
5.18
All Time Low Change
185%
All Time Low Date
2016-11-02
ATR
0.57
Ch YTD
34.67
High
14.76
High52
16.72
High52 Date
2025-05-29
High52ch
-11.72%
Low
14.06
Low52
8.12
Low52 Date
2026-02-10
Low52ch
81.82%
Ma50ch
38.41%
Price vs 200-day SMA
40.56%
RSI
75.62
RSI Monthly
45.84
RSI Weekly
63.05
Sharpe ratio
0.34x
Sortino ratio
0.64
Total Return
-3.55%
Tr YTD
34.67
Tr1m
66.86%
Tr1w
3.36%
Tr3m
79.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -156.2M
Operating margin
-26.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
97,324,427%
Net Borrowing
-390,881,651.3
Shares Insiders
8.6%
Shares Institutions
76.46%
Shares Qo Q
1.7%
Shares Yo Y
3.55%
Short Ratio
4.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
EUR -161.6M
Average Volume
87.25x
Bv Per Share
2.48
CAPEX
EUR -18.4M
Ch10y
51.23
Ch1m
66.86
Ch1w
3.36
Ch1y
7.78
Ch3m
79.43
Ch3y
-75.67
Ch5y
-90.81
Ch6m
57.26
Change
7.31%
Change From Open
4.98
Close
13.76
Days Gap
2.18
Depreciation Amortization
11,812,110.7
Dollar Volume
7,232.4
Earnings Date
2026-04-30
EBIT
EUR -156.2M
EBITDA
EUR -144.2M
EPS
EUR -1.33
F Score
3
FCF
EUR -41.7M
FCF EV Yield
-2.62x
Financing CF
-396,144,479
Fiscal Year End
December
Founded
2,000
Income Tax
EUR -1.9M
Investing CF
391,581,614
Is Primary Listing
0
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Ma150
10.65
Ma150ch
38.62%
Ma20
11.13
Ma20ch
32.64%
Net CF
-27,846,401
Open
14.06
Position In Range
100
Ppne
123,007,911.6
Price Date
2026-05-08
Ptbv Ratio
6.14
Relative Volume
7.81x
Revenue
584,919,262x
SBC By Revenue
20.51x
Share Based Comp
119,938,050
Tax By Revenue
-0.32x
Tr6m
57.26%
Volume
490
Z Score
0.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/038 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/038 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+7.8%
S&P 500 1Y: n/a
3Y total return
-75.7%
S&P 500 3Y: n/a
5Y total return
-90.8%
S&P 500 5Y: n/a
10Y total return
+51.2%
S&P 500 10Y: n/a
Ownership

Who owns FRA/038?

Insider, institutional, and short-interest positioning.

Institutional ownership
+76.5%
Share of float held by funds and institutions
Insider ownership
+8.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.3 days to cover
Y/Y dilution
+3.5%
Negative means the company is buying back shares.
Technical

FRA/038 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
75.6
Above 70: short-term overbought
Price vs 200-day MA
+40.6%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.34
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/038

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/038 stock rating?

fra/038 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/038 analysis?

The full report lives at /stocks/fra/038/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/038?

The latest report frames fra/038 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/038 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.